We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

17 Jun 2026 - 19 Jun 2026
08 Jul 2026 - 10 Jul 2026

Lactate Analyzer with POC Hematocrit Compensation Launched

By LabMedica International staff writers
Posted on 10 Dec 2013
A lactate analyzer, originally developed for coaches and sportsmen, has additional features that make it suitable for further medical applications. More...


Launched by EKF Diagnostics (Cardiff, United Kingdom), the upgraded Lactate Scout+ includes built-in hematocrit compensation. This makes it suitable for a range of medical applications including cord blood lactate (CBL) analysis that can give a picture of acid-base balance at birth and is particularly recommended after high risk deliveries, fetal scalp lactate (FSL), that can be used to confirm abnormal cardiotocography values and helps to determine the need for immediate intervention in complicated births where there may be risk of insufficient fetal oxygen supply.

The in-built compensation for hematocrit (Hct) within Lactate Scout+ ensures accurate lactate measurements even at high (>50%) or low (<35%) Hct levels. The new analyzer’s Hct range is 20%–70%, which means patients with either very low Hct levels (e.g., after blood loss) or very high levels (e.g., professional athletes and neonates) can be accurately assessed. This makes Lactate Scout+ ideal for a range of medical applications. These include cardio training, weight reduction, and fitness applications which are already well established, as well as new applications in obstetrics.

EKF CEO, Julian Baines commented, “The launch of the new version of Lactate Scout+ reaffirms EKF Diagnostics’ long term expertise in lactate measurement.”

Related Links:

EKF Diagnostics



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Automated Coagulation Analyzer
Hemolumi H6
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers use a novel immobilized liposome-bound gel beads method to measure CEC levels and their association with cardiovascular risks (Photo courtesy of Institute of Science Tokyo)

Simple Blood-Based Cholesterol Efflux Assay Identifies High-Risk Coronary Plaque Features

Unstable coronary plaques are difficult to identify before they trigger acute cardiovascular events. Standard high-density lipoprotein (HDL) measurements do not always capture how well HDL particles function... Read more

Pathology

view channel
Image: Overview of the uncertainty-aware lensfree computational pathology platform for automated HER2 assessment. A compact lensfree holographic imaging system captures diffraction patterns from immunohistochemically stained breast tissue samples, which are computationally reconstructed and analyzed using deep neural networks with Bayesian uncertainty quantification. (Photo courtesy of Ozcan Lab, UCLA)

Uncertainty-Aware AI Platform Supports Automated HER2 Assessment in Breast Cancer

Accurate assessment of human epidermal growth factor receptor 2 (HER2) is critical for breast cancer diagnosis and treatment selection, yet scoring variability and infrastructure requirements can complicate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.